VIVS
VivoSim Labs, Inc.
Price Chart
Latest Quote
$0.15
-0.00 (-3.33%)
Current Price
| Previous Close | $0.15 |
| Open | $0.15 |
| Day High | $0.15 |
| Day Low | $0.14 |
| Volume | 109,540 |
Stock Information
| Shares Outstanding | 16.59M |
| Total Debt | $316K |
| Cash Equivalents | $1.67M |
| Revenue | $112K |
| Net Income | $-12.34M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $2.41M |
| EPS (TTM) | $-4.47 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $878K |
| Sales | $112K |
| Income | $-12.34M |
| Book/sh | $-0.73 |
| Cash/sh | $0.10 |
| Employees | 15 |
Financial Ratios
| Quick Ratio | 0.90 |
| Current Ratio | 1.70 |
Returns & Margins
| ROA | -89.50% |
| ROE | -343.10% |
| Operating Margin | -15327.78% |
Ownership
| Insider Ownership | 2.67% |
| Institutional Ownership | 11.15% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 21.52 |
| P/B | -0.20 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.17 |
| SMA50 | $0.23 |
| SMA200 | $1.09 |
| RSI | 31.68 |
| ATR | 0.0162 |
| Shares Float | 14.46M |
| Short Float | 3.61% |
| Short Ratio | 0.58 |
| Volatility | 1.49 |
| Rel Volume | 0.12 |
Performance History
| Week | -19.28% |
| Month | -27.35% |
| Quarter | -62.74% |
| 6 Months | -89.91% |
| YTD | -92.27% |
| Year | -93.66% |
| 3 Years | -98.97% |
| 5 Years | -99.81% |
| 10 Years | -99.98% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-28 | $0.15 | 109,540 |
| 2026-10-27 | $0.15 | 476,200 |
| 2026-10-26 | $0.15 | 566,900 |
| 2026-10-23 | $0.15 | 745,500 |
| 2026-10-22 | $0.16 | 2,658,100 |
| 2026-10-21 | $0.18 | 2,647,900 |
| 2026-10-20 | $0.17 | 692,300 |
| 2026-10-19 | $0.16 | 357,200 |
| 2026-10-16 | $0.16 | 822,900 |
| 2026-10-15 | $0.17 | 3,512,500 |
| 2026-10-14 | $0.16 | 356,600 |
| 2026-10-13 | $0.17 | 181,000 |
| 2026-10-12 | $0.17 | 1,096,800 |
| 2026-10-09 | $0.18 | 332,200 |
| 2026-10-08 | $0.18 | 872,700 |
| 2026-10-07 | $0.19 | 881,200 |
| 2026-10-06 | $0.20 | 374,900 |
| 2026-10-05 | $0.21 | 444,300 |
| 2026-10-02 | $0.20 | 804,500 |
| 2026-10-01 | $0.21 | 185,300 |
| 2026-09-30 | $0.21 | 558,100 |
| 2026-09-29 | $0.20 | 647,800 |
| 2026-09-28 | $0.22 | 423,900 |
About VivoSim Labs, Inc.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and build functional 3D human tissues through its proprietary technologies that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on VIVS.
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $0 | $5,000 | $0 | - |
| Cost Of Revenue | $0 | $5,000 | $0 | - |
| Total Revenue | $131,000 | $144,000 | $109,000 | $370,000 |
| Operating Revenue | $131,000 | $144,000 | $109,000 | $370,000 |
| Expenses | ||||
| Interest Expense | $12,000 | $10,000 | $0 | - |
| Total Expenses | $11,618,000 | $12,760,000 | $15,195,000 | $18,101,000 |
| Other Income Expense | $-2,609,000 | $10,000,000 | $12,000 | $20,000 |
| Other Non Operating Income Expenses | $-2,703,000 | - | - | - |
| Net Non Operating Interest Income Expense | $255,000 | $130,000 | $405,000 | $454,000 |
| Interest Expense Non Operating | $12,000 | $10,000 | $0 | - |
| Operating Expense | $11,618,000 | $12,755,000 | $15,195,000 | $18,101,000 |
| General And Administrative Expense | $7,413,000 | $7,691,000 | $9,644,000 | $9,088,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-13,843,000 | $-2,488,000 | $-14,671,000 | $-17,259,000 |
| Net Interest Income | $255,000 | $130,000 | $405,000 | $454,000 |
| Interest Income | $267,000 | $140,000 | $405,000 | $454,000 |
| Normalized Income | $-13,937,000 | $-10,388,000 | $-14,683,000 | $-17,279,000 |
| Net Income From Continuing And Discontinued Operation | $-13,843,000 | $-2,488,000 | $-14,671,000 | $-17,259,000 |
| Total Operating Income As Reported | $-11,487,000 | $-12,616,000 | $-15,086,000 | $-17,731,000 |
| Net Income Common Stockholders | $-13,843,000 | $-2,488,000 | $-14,671,000 | $-17,259,000 |
| Net Income | $-13,843,000 | $-2,488,000 | $-14,671,000 | $-17,259,000 |
| Net Income Including Noncontrolling Interests | $-13,843,000 | $-2,488,000 | $-14,671,000 | $-17,259,000 |
| Net Income Continuous Operations | $-13,843,000 | $-2,488,000 | $-14,671,000 | $-17,259,000 |
| Pretax Income | $-13,841,000 | $-2,486,000 | $-14,669,000 | $-17,257,000 |
| Special Income Charges | $0 | $10,000,000 | $0 | $-9,000 |
| Interest Income Non Operating | $267,000 | $140,000 | $405,000 | $454,000 |
| Operating Income | $-11,487,000 | $-12,616,000 | $-15,086,000 | $-17,731,000 |
| Depreciation Amortization Depletion Income Statement | $16,000 | $39,000 | $53,000 | $128,000 |
| Depreciation And Amortization In Income Statement | $16,000 | $39,000 | $53,000 | $128,000 |
| Gross Profit | $131,000 | $139,000 | $109,000 | - |
| Per Share | ||||
| Diluted EPS | $-5.35 | $-1.70 | $-19.25 | $-23.76 |
| Basic EPS | $-5.35 | $-1.70 | $-19.25 | $-23.76 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $2,100,000 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-13,708,000 | $-12,210,000 | $-14,401,000 | $-17,458,000 |
| Total Unusual Items | $94,000 | $10,000,000 | $12,000 | $20,000 |
| Total Unusual Items Excluding Goodwill | $94,000 | $10,000,000 | $12,000 | $20,000 |
| Reconciled Depreciation | $215,000 | $266,000 | $280,000 | $293,000 |
| EBITDA (Bullshit earnings) | $-13,614,000 | $-2,210,000 | $-14,389,000 | $-17,438,000 |
| EBIT | $-13,829,000 | $-2,476,000 | $-14,669,000 | $-17,731,000 |
| Diluted Average Shares | $2,588,327 | $1,463,609 | $762,076 | $726,085 |
| Basic Average Shares | $2,588,327 | $1,463,609 | $762,076 | $726,085 |
| Diluted NI Availto Com Stockholders | $-13,843,000 | $-2,488,000 | $-14,671,000 | $-17,259,000 |
| Tax Provision | $2,000 | $2,000 | $2,000 | $2,000 |
| Gain On Sale Of Ppe | $0 | $10,000,000 | $0 | $-9,000 |
| Gain On Sale Of Security | $94,000 | - | $12,000 | $29,000 |
| Research And Development | $4,189,000 | $5,025,000 | $5,498,000 | $8,885,000 |
| Selling General And Administration | $7,413,000 | $7,691,000 | $9,644,000 | $9,088,000 |
| Other Gand A | $7,166,000 | $7,245,000 | $8,274,000 | $7,184,000 |
| Salaries And Wages | $247,000 | $446,000 | $1,370,000 | $1,904,000 |
Fetched: 2026-09-19
Balance Sheet (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,099,000 | $10,492,000 | $3,601,000 | $15,329,000 |
| Total Assets | $7,386,000 | $14,650,000 | $6,349,000 | $20,313,000 |
| Total Non Current Assets | $759,000 | $2,519,000 | $2,413,000 | $3,265,000 |
| Other Non Current Assets | $146,000 | $1,233,000 | $445,000 | $658,000 |
| Current Assets | $6,627,000 | $12,131,000 | $3,936,000 | $17,048,000 |
| Prepaid Assets | $557,000 | $777,000 | $701,000 | $820,000 |
| Receivables | $1,046,000 | $30,000 | $33,000 | $152,000 |
| Other Receivables | $1,014,000 | - | - | - |
| Accounts Receivable | $32,000 | $30,000 | $33,000 | $152,000 |
| Cash Cash Equivalents And Short Term Investments | $5,024,000 | $11,312,000 | $2,901,000 | $16,007,000 |
| Cash And Cash Equivalents | $5,024,000 | $11,312,000 | $2,901,000 | $15,301,000 |
| Other Current Assets | - | $12,000 | $4,000 | $69,000 |
| Inventory | - | $0 | $297,000 | $0 |
| Non Current Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $447,000 | $942,000 | $1,394,000 | $1,805,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $421,000 | $888,000 | $1,313,000 |
| Current Debt And Capital Lease Obligation | $447,000 | $521,000 | $506,000 | $492,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,485,000 | $4,158,000 | $2,748,000 | $4,984,000 |
| Total Non Current Liabilities Net Minority Interest | $5,700,000 | $421,000 | $888,000 | $1,313,000 |
| Derivative Product Liabilities | $5,700,000 | $0 | - | - |
| Current Liabilities | $2,785,000 | $3,737,000 | $1,860,000 | $3,671,000 |
| Other Current Liabilities | $336,000 | $346,000 | - | - |
| Payables And Accrued Expenses | $1,580,000 | $2,218,000 | $818,000 | $2,570,000 |
| Payables | $1,021,000 | $1,644,000 | $627,000 | $331,000 |
| Accounts Payable | $1,021,000 | $1,644,000 | $627,000 | $331,000 |
| Equity | ||||
| Common Stock Equity | $-1,099,000 | $10,492,000 | $3,601,000 | $15,329,000 |
| Total Equity Gross Minority Interest | $-1,099,000 | $10,492,000 | $3,601,000 | $15,329,000 |
| Stockholders Equity | $-1,099,000 | $10,492,000 | $3,601,000 | $15,329,000 |
| Retained Earnings | $-356,000,000 | $-342,157,000 | $-339,669,000 | $-324,998,000 |
| Gains Losses Not Affecting Retained Earnings | - | - | $0 | $2,000 |
| Other Equity Adjustments | - | - | - | $2,000 |
| Other | ||||
| Ordinary Shares Number | $2,894,519 | $1,898,065 | $839,810 | $726,408 |
| Share Issued | $2,894,519 | $1,898,068 | $839,813 | $726,411 |
| Tangible Book Value | $-1,099,000 | $10,492,000 | $3,601,000 | $15,329,000 |
| Invested Capital | $-1,099,000 | $10,492,000 | $3,601,000 | $15,329,000 |
| Working Capital | $3,842,000 | $8,394,000 | $2,076,000 | $13,377,000 |
| Capital Lease Obligations | $447,000 | $942,000 | $1,394,000 | $1,805,000 |
| Total Capitalization | $-1,099,000 | $10,492,000 | $3,601,000 | $15,329,000 |
| Treasury Stock | $0 | $1,000 | $1,000 | $1,000 |
| Additional Paid In Capital | $354,898,000 | $352,648,000 | $343,270,000 | $340,317,000 |
| Capital Stock | $3,000 | $2,000 | $1,000 | $9,000 |
| Common Stock | $3,000 | $2,000 | $1,000 | $9,000 |
| Long Term Capital Lease Obligation | $0 | $421,000 | $888,000 | $1,313,000 |
| Current Capital Lease Obligation | $447,000 | $521,000 | $506,000 | $492,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $422,000 | $652,000 | $536,000 | $609,000 |
| Current Accrued Expenses | $559,000 | $574,000 | $191,000 | $2,239,000 |
| Net PPE | $613,000 | $1,286,000 | $1,968,000 | $2,607,000 |
| Accumulated Depreciation | $-1,734,000 | $-1,521,000 | $-1,258,000 | $-1,276,000 |
| Gross PPE | $2,347,000 | $2,807,000 | $3,226,000 | $3,883,000 |
| Other Properties | $1,630,000 | $1,630,000 | $1,617,000 | $1,575,000 |
| Machinery Furniture Equipment | $310,000 | $310,000 | $310,000 | $603,000 |
| Buildings And Improvements | $407,000 | $867,000 | $1,299,000 | $1,705,000 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | $3 | $3 | $3 |
| Finished Goods | - | $0 | $297,000 | $0 |
| Other Short Term Investments | - | - | $0 | $706,000 |
Fetched: 2026-09-19
Cash Flow Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-10,827,000 | $-9,474,000 | $-14,695,000 | $-12,804,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-10,827,000 | $-9,461,000 | $-14,653,000 | $-12,408,000 |
| Cash Flow From Continuing Operating Activities | $-10,827,000 | $-9,461,000 | $-14,653,000 | $-12,408,000 |
| Operating Gains Losses | $44,000 | $-10,000,000 | $-12,000 | $-20,000 |
| Investing Activities | ||||
| Investing Cash Flow | $94,000 | $9,025,000 | $816,000 | $-966,000 |
| Cash Flow From Continuing Investing Activities | $94,000 | $9,025,000 | $816,000 | $-966,000 |
| Capital Expenditure | - | $-13,000 | $-42,000 | $-396,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,808,000 | $8,847,000 | $1,437,000 | $0 |
| Financing Cash Flow | $4,445,000 | $8,847,000 | $1,437,000 | $0 |
| Cash Flow From Continuing Financing Activities | $4,445,000 | $8,847,000 | $1,437,000 | $0 |
| Net Other Financing Charges | $-363,000 | - | - | - |
| Net Common Stock Issuance | $4,808,000 | $8,847,000 | $1,437,000 | $0 |
| Common Stock Issuance | $4,808,000 | $8,847,000 | $1,437,000 | $0 |
| Repurchase Of Capital Stock | - | - | - | - |
| Other | ||||
| Interest Paid Supplemental Data | $12,000 | $10,000 | $0 | - |
| Income Tax Paid Supplemental Data | $2,000 | $2,000 | $2,000 | $2,000 |
| End Cash Position | $5,167,000 | $11,455,000 | $3,044,000 | $15,444,000 |
| Beginning Cash Position | $11,455,000 | $3,044,000 | $15,444,000 | $28,818,000 |
| Changes In Cash | $-6,288,000 | $8,411,000 | $-12,400,000 | $-13,374,000 |
| Net Investment Purchase And Sale | $94,000 | $38,000 | $858,000 | $-570,000 |
| Sale Of Investment | $94,000 | $3,000,000 | $11,718,000 | $10,384,000 |
| Purchase Of Investment | $0 | $-2,962,000 | $-10,860,000 | $-10,954,000 |
| Net PPE Purchase And Sale | $0 | $8,987,000 | $-42,000 | $-396,000 |
| Sale Of PPE | $0 | $9,000,000 | $0 | - |
| Purchase Of PPE | $0 | $-13,000 | $-42,000 | $-396,000 |
| Change In Working Capital | $-695,000 | $1,037,000 | $-2,022,000 | $2,306,000 |
| Change In Other Current Liabilities | $-495,000 | $-452,000 | $-411,000 | - |
| Change In Payables And Accrued Expense | $-868,000 | $1,734,000 | $-1,825,000 | $2,211,000 |
| Change In Accrued Expense | $-245,000 | $717,000 | $-2,121,000 | $2,359,000 |
| Change In Payable | $-623,000 | $1,017,000 | $296,000 | $-148,000 |
| Change In Account Payable | $-623,000 | $1,017,000 | $296,000 | $-148,000 |
| Change In Prepaid Assets | $670,000 | $253,000 | $392,000 | $177,000 |
| Change In Inventory | $0 | $-501,000 | $-297,000 | $0 |
| Change In Receivables | $-2,000 | $3,000 | $119,000 | $-152,000 |
| Changes In Account Receivables | $-2,000 | $3,000 | $119,000 | $-152,000 |
| Other Non Cash Items | $3,149,000 | $432,000 | $406,000 | - |
| Stock Based Compensation | $303,000 | $532,000 | $1,508,000 | $2,377,000 |
| Asset Impairment Charge | $0 | $798,000 | $0 | - |
| Amortization Of Securities | $0 | $-38,000 | $-142,000 | $-105,000 |
| Depreciation Amortization Depletion | $215,000 | $266,000 | $280,000 | $293,000 |
| Depreciation And Amortization | $215,000 | $266,000 | $280,000 | $293,000 |
| Earnings Losses From Equity Investments | $-94,000 | $0 | $-12,000 | $-29,000 |
| Gain Loss On Investment Securities | $138,000 | - | - | - |
| Net Income From Continuing Operations | $-13,843,000 | $-2,488,000 | $-14,671,000 | $-17,259,000 |
| Change In Other Working Capital | - | - | $-5,000 | $70,000 |
| Gain Loss On Sale Of PPE | - | - | $0 | $9,000 |
| Proceeds From Stock Option Exercised | - | - | - | - |
| Common Stock Payments | - | - | - | - |
Fetched: 2026-09-19